paion.de Report : Visit Site

Technical data of the paion.de

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host paion.de. Currently, hosted in Germany and its service provider is DomainFactory GmbH .

the related websites

bloomberg.com hl.co.uk pevonia.co.uk 3dimensions.ltd.uk lse.co.uk mhra.gov.uk chambersandpartners.com users.tinyonline.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.29 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

de en company about paion history management supervisory board contact germany uk career what does paioneering mean to us? what paioneers can expect job offers information events information request remimazolam sedation & anesthesia market overview procedural sedation (u.s.) general anesthesia (europe) product information about remimazolam clinical trials medical information pipeline portfolio overview remimazolam glossary a_z partnering strategy partnering strategy remimazolam strategy licensing projects remimazolam media and investors at a glance general information contact newsroom press releases ad-hoc releases directors' dealings holdings in company information on shares chart & fact sheet analysts capital actions information on cenes acquisition investorcenter financial reports presentations corporate calendar information request corporate governance declaration on corporate governance articles of association declaration of conformity code of conduct annual general meeting 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 our vision is to be the accepted paioneer in sedation and anesthesia; helping advance patient care. prev next company remimazolam media and investors paion is a specialty pharmaceutical company that develops innovative products for sedation and anesthesia including commercialization. learn more about paion our vision our vision is to be the accepted paioneer in sedation and anesthesia; helping advance patient care. paion's strategy & partnering remimazolam paion’s lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate for which paion has completed the clinical development for use in procedural sedation in the u.s. paion's remimazolam q1 2018 teleconference & webcast 09 may 2018 presentation replay news 06/21/2018 ad hoc release: paion ag raises eur 5.2 million in private placement paion ag raises eur 5.2 million in private placement read more 06/21/2018 press release: paion ag raises eur 5.2 million in private placement paion ag raises eur 5.2 million in private placement read more 05/23/2018 voting results agm voting results agm read more 03/09/2017 press release: paion ag: change in management board paion ag: change in management board read more 02/28/2017 press release: paion ag announces successful completion of capital increase with... paion ag announces successful completion of capital increase with... read more 02/07/2017 press release: paion ag: capital increase; preliminary, unaudited key group... paion ag: capital increase; preliminary, unaudited key group... read more 12/21/2016 press release: paion announces clinical development progress with remimazolam by... paion announces clinical development progress with remimazolam by... read more 10/19/2016 press release: positive remimazolam phase iii colonoscopy results presented at... positive remimazolam phase iii colonoscopy results presented at... read more 09/22/2016 press release: remimazolam phase iii colonoscopy data to be presented at the... remimazolam phase iii colonoscopy data to be presented at the... read more 09/06/2016 press release: paion announces clinical development progress with remimazolam by... paion announces clinical development progress with remimazolam by... read more 06/29/2016 press release: paion completes private placement in the amount of eur 9.6... paion completes private placement in the amount of eur 9.6... read more 06/19/2016 press release: paion reports positive remimazolam headline data in pivotal u.s.... paion reports positive remimazolam headline data in pivotal u.s.... read more 04/11/2016 press release: paion successfully completes patient recruitment in phase iii... paion successfully completes patient recruitment in phase iii... read more to the newsroom paion chart visit us on linkedin! copyright © paion ag i all rights reserved imprint privacy statement general terms and conditions martinstrasse 10-12 | 52062 aachen | deutschland tel.: +49 241 4453-0 | fax.: +49 241 4453-100 | e-mail: [email protected] -- company about paion + history management supervisory board contact + germany uk career + what does paioneering mean to us? what paioneers can expect job offers information + events information request remimazolam sedation & anesthesia market + overview procedural sedation (u.s.) general anesthesia (europe) product information + about remimazolam clinical trials medical information pipeline portfolio + overview remimazolam glossary + a_z partnering strategy + partnering strategy remimazolam strategy licensing projects + remimazolam media and investors at a glance + general information contact newsroom + press releases ad-hoc releases directors' dealings holdings in company information on shares + chart & fact sheet analysts capital actions information on cenes acquisition investorcenter + financial reports presentations corporate calendar information request corporate governance + declaration on corporate governance articles of association declaration of conformity code of conduct annual general meeting + 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

URL analysis for paion.de

https://www.paion.com/media-and-investors/information-on-shares/chart-fact-sheet/
https://www.paion.com/media-and-investors/newsroom/ad-hoc-releases/
https://www.paion.com/media-and-investors/investorcenter/financial-reports/
https://www.paion.com/footernav/privacy-statement/
https://www.paion.com/media-and-investors/corporate-governance/declaration-on-corporate-governance/
https://www.paion.com/media-and-investors/annual-general-meeting/2017/
https://www.paion.com/newsdetails/press-release-paion-ag-change-in-management-board/?tx_news_pi1%5bcontroller%5d=news&tx_news_pi1%5baction%5d=detail&chash=279b9f2c56faa42de64e1cf13d8a4e6c
https://www.paion.com/remimazolam/sedation-anesthesia-market/general-anesthesia-europe/
https://www.paion.com/pipeline/portfolio/overview/
https://www.paion.com/company/about-paion/supervisory-board/
https://www.paion.com/media-and-investors/annual-general-meeting/2010/
https://www.paion.com/media-and-investors/annual-general-meeting/2018/
https://www.paion.com/newsdetails/press-release-positive-remimazolam-phase-iii-colonoscopy-results-presented-at-the-2016-american-college-of-gastroenterology-annual-scientific-meeting/?tx_news_pi1%5bcontroller%5d=news&tx_news_pi1%5baction%5d=detail&chash=6a85f87a990a9b3371ce458065e610a8
https://www.paion.com/media-and-investors/information-on-shares/capital-actions/
https://www.paion.com/media-and-investors/at-a-glance/general-information/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

% Copyright (c) 2010 by DENIC
% Version: 2.0
%
% Restricted rights.
%
% Terms and Conditions of Use
%
% The data in this record is provided by DENIC for informational purposes only.
% DENIC does not guarantee its accuracy and cannot, under any circumstances,
% be held liable in case the stored information would prove to be wrong,
% incomplete or not accurate in any sense.
%
% All the domain data that is visible in the whois service is protected by law.
% It is not permitted to use it for any purpose other than technical or
% administrative requirements associated with the operation of the Internet.
% It is explicitly forbidden to extract, copy and/or use or re-utilise in any
% form and by any means (electronically or not) the whole or a quantitatively
% or qualitatively substantial part of the contents of the whois database
% without prior and explicit written permission by DENIC.
% It is prohibited, in particular, to use it for transmission of unsolicited
% and/or commercial and/or advertising by phone, fax, e-mail or for any similar
% purposes.
%
% By maintaining the connection you assure that you have a legitimate interest
% in the data and that you will only use it for the stated purposes. You are
% aware that DENIC maintains the right to initiate legal proceedings against
% you in the event of any breach of this assurance and to bar you from using
% its whois service.
%
% The DENIC whois service on port 43 never discloses any information concerning
% the domain holder/administrative contact. Information concerning the domain
% holder/administrative contact can be obtained through use of our web-based
% whois service available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%

Domain: paion.de
Nserver: ns1.eurixx.com
Nserver: ns1.eurixx.de
Nserver: ns2.eurixx.com
Nserver: ns2.eurixx.de
Status: connect
Changed: 2015-03-13T11:57:00+01:00

[Tech-C]
Type: PERSON
Name: Fritz, Stefan
Organisation: synaix IT GmbH
Address: Im Suesterfeld 6
PostalCode: 52072
City: Aachen
CountryCode: DE
Phone: +49 241 41300
Fax: +49 241 4130480
Email: [email protected]
Changed: 2016-10-10T10:17:01+02:00

[Zone-C]
Type: PERSON
Name: Fritz, Stefan
Organisation: synaix IT GmbH
Address: Im Suesterfeld 6
PostalCode: 52072
City: Aachen
CountryCode: DE
Phone: +49 241 41300
Fax: +49 241 4130480
Email: [email protected]
Changed: 2016-10-10T10:17:01+02:00

  REGISTRAR DENIC eG

  REFERRER http://www.denic.de/

SERVERS

  SERVER de.whois-servers.net

  ARGS -T dn,ace paion.de

  PORT 43

  TYPE domain

DOMAIN

  NAME paion.de

NSERVER

  NS1.EURIXX.COM 5.61.84.200

  NS1.EURIXX.DE 5.61.84.199

  NS2.EURIXX.COM 5.61.85.200

  NS2.EURIXX.DE 5.61.85.199

  STATUS connect

  CHANGED 2016-10-10

TECH

  NAME Fritz, Stefan

  ORGANIZATION synaix IT GmbH

ADDRESS

STREET
Im Suesterfeld 6

  PCODE 52072

  CITY Aachen

  COUNTRY DE

  PHONE +49 241 41300

  FAX +49 241 4130480

  EMAIL [email protected]

ZONE

  NAME Fritz, Stefan

  ORGANIZATION synaix IT GmbH

ADDRESS

STREET
Im Suesterfeld 6

  PCODE 52072

  CITY Aachen

  COUNTRY DE

  PHONE +49 241 41300

  FAX +49 241 4130480

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .